Last reviewed · How we verify

NCT06286501: LumoPrevent

Targeting of Preventive Treatment for Adolescents at Risk of Oral Diseases

Recruiting now NA Last updated 6 August 2025
What this trial tests

NA trial testing Lumoral Treatment in Dental Caries in Children in 120 participants. Currently enrolling.

Timeline
18 April 2024
Primary endpoint
30 September 2025
31 December 2025

Quick facts

Lead sponsorWellbeing Services County of Pirkanmaa
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment120
Start date18 April 2024
Primary completion30 September 2025
Estimated completion31 December 2025
Sites1 location across Finland

Drugs / interventions tested

Conditions studied

Sponsor

Wellbeing Services County of Pirkanmaa

Who can join

Adults 14 to 16, any sex, with Dental Caries in Children or Dental Plaque. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to identify adolescent patients that are at risk of developing oral diseases, and to assess if targeted preventive oral treatment with antibacterial dual-light therapy as an adjunctive treatment method can have a positive impact in preventing oral diseases from emerging.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Lumoral Treatment

Trials testing the same drug.

Other recruiting trials for Dental Caries in Children

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06286501.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing